Page 2 - ஆர்வமுள்ள தொழில்நுட்பம் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
11 Best Gaming Stocks to Buy Now - Insider Monkey
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.
Audio Software Plugin Market Will Hit Big Revenues In Future | Microsoft, Blue Cat Audio, Avid Technology
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
Avid Technology to Participate in the J P Morgan 49th Annual Global Technology, Media and Communications Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Operator
Good afternoon, ladies and gentlemen and welcome to the Avid Technology s First Quarter 2021 Earnings Conference Call. [Operator Instructions]
Now let me turn the call over to your host for today s call, Whit Rappole, VP of Investor Relations.
Whit Rappole
Vice President-Corporate Development and Investor Relations
Thank you, operator. Good afternoon, everyone. And thank you for joining us today for Avid Technology s first quarter 2021 earnings call for the period ending March 31, 2021. My name is Whit Rappole, Avid s Vice President for Corporate Development and Investor Relations. With me this afternoon are Jeff Rosica, our Chief Executive Officer and President; and Ken Gayron, our Chief Financial Officer and EVP. In their prepared remarks, Jeff will provide an overview of our business and then Ken will provide a detailed review of our financial and operating results, followed by time for your questions.
Shares of Stealth BioTherapeutics Corp (NASDAQ: MITO) got a boost, shooting 33% to $1.5950. Stealth BioTherapeutics presented at the Association for Research in Vision and Ophthalmology meeting with positive data from a post hoc analysis of the Phase 1 ReCLAIM study evaluating elamipretide in patients with non-central geographic atrophy and high risk drusen associated with dry age-related macular degeneration.
Avid Technology, Inc. (NASDAQ: AVID) shares were also up, gaining 21% to $26.28 after the company reported better-than-expected Q1 results and raised FY21 guidance.
Equities Trading DOWN
James River Group Holdings, Ltd. (NASDAQ: JRVR) shares tumbled 30% to $32.34 after the company swung to a loss in the first quarter. The company also priced its 5.65 million share common stock offering at $31 per share.